Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
698 studies found for:    "Venous Thrombosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis
Condition: Deep Venous Thrombosis
Intervention: Procedure: Percutaneous mechanical thrombectomy
2 Recruiting The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)
Condition: Cerebral Venous Thrombosis
Intervention: Other: ELISA Test
3 Completed Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
Condition: Deep Venous Thrombosis
Interventions: Drug: Idrabiotaparinux sodium;   Drug: Idraparinux sodium;   Drug: Avidin;   Drug: Placebo (for Avidin)
4 Completed Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis
Condition: Deep Venous Thrombosis
Intervention:
5 Withdrawn Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery
Condition: Asymptotic Venous Thrombosis
Intervention: Drug: Enoxaparin
6 Completed Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Clinical and Radiological Correlations
Condition: Cerebral Venous Thrombosis
Intervention:
7 Withdrawn Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
Condition: Venous Thrombosis
Intervention: Drug: 99mTc-rBitistatin
8 Completed Oral Rivaroxaban in Children With Venous Thrombosis
Condition: Venous Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
9 Completed Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication
Condition: Venous Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
10 Enrolling by invitation Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
Condition: Venous Thrombosis
Interventions: Device: a manual spiral thrombus broken suction device;   Procedure: catheter-directed thrombolysis;   Drug: low-molecular-weight heparin calcium;   Drug: urokinase
11 Completed Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
Condition: Deep Venous Thrombosis
Interventions: Drug: unfractionated heparin;   Drug: Tinzaparin (Leo)
12 Recruiting Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
Condition: Deep Venous Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
13 Recruiting Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
Condition: Deep Venous Thrombosis
Interventions: Drug: GMI-1271;   Drug: Enoxaparin Sodium (Lovenox®)
14 Withdrawn Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients
Condition: Lower Extremity Deep Venous Thrombosis
Interventions: Drug: heparin;   Drug: enoxaparin
15 Completed Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)
Condition: Venous Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
16 Completed Optimal Duration of Anticoagulation in Deep Venous Thrombosis
Conditions: Deep Vein Thrombosis of Lower Limb;   Lower Extremity Deep Venous Thrombosis Recurrent
Intervention: Drug: Sodium warfarin
17 Completed Simplification of the Diagnosis of Deep Vein Thrombosis
Condition: Deep Venous Thrombosis
Intervention: Other: Extensive search for isolated calf DVT
18 Recruiting Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion
Condition: Venous Thrombosis
Intervention:
19 Completed
Has Results
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
Condition: Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Enoxaparin followed by VKA
20 Completed
Has Results
Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Device: DVT-3000;   Device: SCD Express

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.